This document forms a condition of licence which applies to all management licence holders authorised to possess a linear accelerator for therapeutic purposes and where condition M1737 has been imposed on the authorisation.
Requirements for independent dosimetric auditing of linear accelerators
Details
- Date published
- 03 Feb 2022
Reviewed 16 October 2024